Patent Assignment
Reel/Frame 070531/0487
Confirmatory Grant of Security Interest in United States Patents
Recorded: 2025-03-17
Pages: 32
Assignors
ARBOR PHARMACEUTICALS, LLC
Executed: 2025-03-14
AZURITY PHARMACEUTICALS, INC.
Executed: 2025-03-14
AZURITY PHARMACEUTICALS IRELAND LIMITED
Executed: 2025-03-14
SILVERGATE PHARMACEUTICALS, INC.
Executed: 2025-03-14
Assignee
HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
40 WEST 57TH STREET, 33RD FLOOR, NEW YORK, NEW YORK, 10019
Covered Properties
(189)
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Crystalline Form of Y-Aminobutyric Acid Analog
Treating or Preventing Restless Legs Syndrome Using Prodrugs of Gaba Analogs
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Container and Method for the Preparation, Storage and Dispensing of Compounded Suppositories
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Gaba Analog Prodrug Sustained Release Oral Dosage Forms
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment-Resistant Strains of Head Lice
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Crystalline Form of a (3S)-Aminomethyl-5-Methyl-Hexanoic Acid Prodrug and Methods of Use
Enantiomerically Resolving Acyloxyalkyl Thiocarbonates Used in Synthesizing Acyloxyalkyl Carbamate Prodrugs
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Methods of Synthesizing N-Hydroxysuccinimidyl Carbonates
Prodrugs of Methyl Hydrogen Fumarate, Pharmaceutical Compositions Thereof, and Methods of Use
Sustained Release Oral Dosage Forms of an R-Baclofen Prodrug
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head Lice
CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Prodrugs of Methyl Hydrogen Fumarate, Pharmaceutical Compositions Thereof, and Methods of Use
Methods of Using Prodrugs of Methyl Hydrogen Fumarate and Pharmaceutical Compositions Thereof
Enalapril Compositions
Patent:
8,568,747 →
Application:
13/670,355 →
Enalapril Compositions
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects
Anhydrous and Hemihydrate Crystalline Forms of an (R)-Baclofen Prodrug, Methods of Synthesis and Methods of Use
CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
Pharmaceutical Compositions of Dimethyl Fumarate
Sotalol Compositions and Uses of the Same
Methods of Using Prodrugs of Methyl Hydrogen Fumarate and Pharmaceutical Compositions Thereof
Method of Making Monomethyl Fumarate
Gaba Analog Prodrug Sustained Release Oral Dosage Forms
Crystalline Forms of (N,N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Pharmaceutical Compositions of Fumaric Acid Esters
Anhydrous and Hemihydrate Crystalline Forms of an (R)-Baclofen Prodrug, Methods of Synthesis and Methods of Use
Lisinopril Formulations
Patent:
9,463,183 →
Application:
14/934,752 →
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
Container and Method for the Preparation, Storage and Dispensing of Compounded Suppositories
Enalapril Formulations
Patent:
9,669,008 →
Application:
15/081,603 →
Composition and Method for Vancomycin Oral Liquid
Crystalline Forms of (N,N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Lisinopril Formulations
Gaba Analog Prodrug Sustained Release Oral Dosage Forms
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Enalapril Compositions
Lisinopril Formulations
Crystalline Forms of (N, N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Enalapril Formulations
Sotalol Compositions and Uses of the Same
Crystalline Forms of (N, N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Amlodipine Formulations
Composition and Method for Vancomycin Oral Liquid
Enalapril Formulations
Lisinopril Formulations
Enalapril Compositions
Non-Aqueous Liquid Nimodipine Compositions
Pharmaceutical Compositions of Fumaric Acid Esters
Enalapril Formulations
Lisinopril Formulations
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Powder for Oral Suspension Containing Lamotrigine
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Patent:
10,456,354 →
Application:
16/176,866 →
Enalapril Formulations
Pharmaceutical Compositions of Dimethyl Fumarate
Enalapril Formulations
Sotalol Compositions and Uses of the Same
Lisinopril Formulations
Composition and Method for Proton Pump Inhibitor Suspension
Apparatus and Method for Filling Bulk Materials into a Container
Oral Pharmaceutical Composition Comprising Zonisamide and Process of Preparation Thereof
Pharmaceutical Compositions of Testosterone
Pharmaceutical Compositions of Meloxicam
Amlodipine Formulations
Non-Aqueous Liquid Nimodipine Compositions
Pharmaceutical Compositions of Posaconazole
Midodrine Hydrochloride Oral Solution and Uses Thereof
Compositions and Kits for Omeprazole Suspension
Patent:
10,751,333 →
Application:
16/513,604 →
Composition and Method for Vancomycin Oral Liquid
Pharmaceutical Compositions of Lurasidone
Non-Aqueous Liquid Nimodipine Compositions
Pharmaceutical Compositions of Dimethyl Fumarate
Pharmaceutical Compositions of Lurasidone
Pharmaceutical Compositions of Nilotinib
Lisinopril Formulations
Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head Lice
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
Amlodipine Formulations
Enalapril Formulations
Composition and Method for Vancomycin Oral Liquid
Amlodipine Formulations
Amlodipine Formulations
Composition and Method for Vancomycin Oral Liquid
Composition and Method for Vancomycin Oral Liquid
Pharmaceutical Compositions of Nilotinib
Enalapril Formulations
Compositions and Kits for Omeprazole Suspension
Compositions and Kits for Omeprazole Suspension
Stable Pharmaceutical Compositions of Dihydroergotamine Mesylate
Sotalol Compositions and Uses of the Same
Amlodipine Formulations
Suspensions and Diluents for Metronidazole and Baclofen
Enalapril Formulations
Amlodipine Formulations
Lisinopril Formulations
Enalapril Formulations
Enalapril Formulations
Amlodipine Formulations
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Compositions and Kits for Omeprazole Suspension
Lisinopril Formulations
Non-Aqueous Liquid Nimodipine Compositions
Pharmaceutical Compositions of Dimethyl Fumarate
Composition and Method for Proton Pump Inhibitor Suspension
Non-Aqueous Liquid Nimodipine Compositions
Compositions and Kits for Omeprazole Suspension
Pharmaceutical Compositions of Cabozantinib
Oral Pharmaceutical Composition Comprising Zonisamide and Process of Preparation Thereof
Pharmaceutical Compositions of Testosterone
Liquid Nimodipine Compositions
Amlodipine Formulations
Suspensions and Diluents for Metronidazole and Baclofen
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Application:
17/822,399 →
Publication:
US 2023/0086729
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Pharmaceutical Compositions of Mifepristone
Stable Pharmaceutical Compositions of Clonidine
Stable Pharmaceutical Compositions of Bendamustine
Patent:
11,707,450 →
Application:
17/877,476 →
Amlodipine Formulations
Stable Pharmaceutical Compositions of Cyclophosphamide
Composition and Method for Vancomycin Oral Liquid
Liquid Nimodipine Compositions
Liquid Nimodipine Compositions
Oral Pharmaceutical Composition Comprising Zonisamide and Process of Preparation Thereof
Application:
17/975,789 →
Publication:
US 2023/0046943
Stable Liquid Compositions of Netupitant and Palonosetron
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Pharmaceutical Compositions of Cabozantinib
Oral Pharmaceutical Composition Comprising Zonisamide and Process of Preparation Thereof
Application:
18/114,410 →
Publication:
US 2023/0241036
Oral Pharmaceutical Composition Comprising Zonisamide and Process of Preparation Thereof
Application:
18/114,469 →
Publication:
US 2023/0218586
Stable Pharmaceutical Compositions of Apixaban
Compositions and Kits for Omeprazole Suspension
Compositions and Kits for Omeprazole Suspension
Compositions and Kits for Omeprazole Suspension
Stable Pharmaceutical Compositions of Hydroxyurea
Application:
18/163,811 →
Publication:
US 2023/0301945
Stable Liquid Compositions of Glucagon
Amlodipine Formulations
Non-Aqueous Liquid Nimodipine Compositions
Pharmaceutical Compositions of Testosterone
Pharmaceutical Compositions of Cabozantinib
Stable Pharmaceutical Compositions of Bendamustine
Oral Dosage Forms Having a High Loading of a Methyl Hydrogen Fumarate Prodrug
Application:
18/333,804 →
Publication:
US 2024/0024249
Stable Pharmaceutical Compositions of Edaravone
Suspensions and Diluents for Metronidazole and Baclofen
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects
Application:
18/419,926 →
Publication:
US 2024/0240229
Stable Pharmaceutical Compositions of Apixaban
Amlodipine Formulations
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Lisinopril Formulations
Pharmaceutical Compositions of Nilotinib
Liquid Nimodipine Compositions
Stable Antiemetic Emulsions for Parenteral Administration
Application:
18/487,330 →
Publication:
US 2024/0156829
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
Application:
18/492,882 →
Publication:
US 2024/0197661
Sotalol Compositions and Uses of the Same
Stable Pharmaceutical Compositions of Bendamustine
Pharmaceutical Compositions of Cabozantinib
Application:
18/523,274 →
Publication:
US 2024/0131018
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Pharmaceutical Compositions of Mifepristone
Pharmaceutical Liquid Compositions of Meloxicam
Pharmaceutical Compositions of Dimethyl Fumarate
Lisinopril Formulations
Oral Pharmaceutical Composition Comprising Zonisamide and Process of Preparation Thereof
Stable Pharmaceutical Compositions of Bendamustine
Amlodipine Formulations
Stable Liquid Compositions of Netupitant and Palonosetron
Pharmaceutical Compositions of Fumaric Acid Esters
Application:
18/799,508 →
Publication:
US 2025/0114457
Stable Liquid Compositions of Glucagon
Application:
18/896,310 →
Publication:
US 2025/0032586
Pharmaceutical Compositions of Cabozantinib
Pharmaceutical Compositions of Mifepristone
Application:
18/904,225 →
Publication:
US 2025/0057855
Pharmaceutical Compositions of Testosterone
Application:
18/911,778 →
Publication:
US 2025/0032508
Stable Pharmaceutical Compositions of Cyclophosphamide
Application:
18/925,887 →
Publication:
US 2025/0049824
Stable Pharmaceutical Compositions of Apixaban
Application:
18/962,435 →
Publication:
US 2025/0082617
Lisinopril Formulations
Stable Pharmaceutical Compositions of Apixaban
Application:
18/985,229 →
Publication:
US 2025/0221978
Non-Aqueous Liquid Nimodipine Compositions
Application:
19/009,120 →
Publication:
US 2025/0221974
Stable Pharmaceutical Compositions of Clonidine
Stable Pharmaceutical Compositions of Hydroxyurea
Application:
19/036,569 →
Publication:
US 2025/0170078
Syringe
Patent:
836,772 →
Application:
29/657,824 →
Syringe
Patent:
851,757 →
Application:
29/668,705 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Aug 16, 2013
From: TOPAZ PHARMACEUTICALS INC.
To: SANOFI - TOPAZ, INC.
Reel/Frame 031024/0502 →
Change of Name
Aug 16, 2013
From: TOPAZ PHARMACEUTICALS LLC
To: TOPAZ PHARMACEUTICALS INC.
Reel/Frame 031031/0051 →
Corrective Assignment to Correct the Execution Date of Inventor Garry T. Gwozdz Previously Recorded on Reel 020836 Frame 0391. Assignor(S) Hereby Confirms the Execution Date of Inventor Garry T. Gwozdz Is 03/26/2008.
Aug 23, 2013
From: GWOZDZ, GARRY T.; SPRING, NICHOLAS
To: TOPAZ PHARMACEUTICALS LLC
Reel/Frame 031076/0144 →
Security Agreement
Dec 16, 2014
From: CUTISPHARMA, INC.; RXEDESIGNEDMEDS, LLC; RXM THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 034648/0882 →
Security Interest
Nov 11, 2015
From: ARBOR PHARMACEUTICALS, LLC
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037013/0177 →
Assignment of Assignor's Interest
Dec 2, 2015
From: SANOFI-TOPAZ INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 037190/0575 →
Security Interest
Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
Assignment of Assignor's Interest
Nov 10, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044090/0243 →
Security Interest
Mar 21, 2018
From: CUTISPHARMA, INC.
To: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., AS COLLATERAL AGENT
Reel/Frame 045300/0385 →
Release of Security Interest
Mar 22, 2018
From: SILICON VALLEY BANK
To: CUTISPHARMA, INC.
Reel/Frame 045311/0168 →
Assignment of Assignor's Interest
Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
Assignment of Assignor's Interest
Jul 25, 2018
From: XENOPORT, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 046633/0753 →
Security Interest
Dec 19, 2018
From: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
To: WHITE OAK HEALTHCARE FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 047815/0615 →
Release of Security Interest
May 17, 2019
From: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., AS COLLATERAL AGENT
To: CUTISPHARMA, INC.
Reel/Frame 049212/0549 →
Release of Security Interest
May 17, 2019
From: WHITE OAK HEALTHCARE FINANCE, LLC, AS AGENT
To: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 049211/0188 →
Security Interest
May 17, 2019
From: CUTISPHARMA, INC.; SILVERGATE PHARMACEUTICALS, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 049209/0272 →
Security Interest
Apr 16, 2021
From: SILVERGATE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055938/0895 →
Security Interest
Apr 16, 2021
From: AZURITY PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055938/0859 →
Assignment of Assignor's Interest
Jun 3, 2021
From: SILVERGATE PHARMACEUTICALS, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 056430/0743 →
Release of Security Interest
Aug 23, 2021
From: GOLDMAN SACHS BANK USA
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 057253/0348 →
Release of Security Interest
Aug 31, 2021
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 057346/0837 →
Security Interest
Sep 20, 2021
From: AZURITY PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057532/0424 →
Release of Security Interest
Sep 20, 2021
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 057531/0556 →
Security Interest
Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
Release of Security Interest
Sep 20, 2021
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 057531/0403 →